Clinical trials in mitochondrial disorders, an update

被引:47
|
作者
Almannai, Mohammed [1 ]
El-Hattab, Ayman W. [2 ]
Ali, May [3 ]
Soler-Alfonso, Claudia [3 ,4 ]
Scaglia, Fernando [3 ,4 ,5 ]
机构
[1] King Fahad Med City, Sect Med Genet, Childrens Hosp, Riyadh, Saudi Arabia
[2] Univ Sharjah, Coll Med, Dept Clin Sci, Sharjah, U Arab Emirates
[3] Baylor Coll Med, Dept Mol & Human Genet, Mark Wallace Tower,Suite 1560,6701 Fannin St, Houston, TX 77030 USA
[4] Texas Childrens Hosp, Mark Wallace Tower,Suite 1560,6701 Fannin St, Houston, TX 77030 USA
[5] Prince Wales Hosp, Joint BCM CUHK Ctr Med Genet, Shatin, Hong Kong, Peoples R China
关键词
Mitochondria; Randomized clinical trials; Mitochondrial augmentation; Antioxidants; Mitochondrial biogenesis; NITRIC-OXIDE PRODUCTION; OPTIMIZED ALLOTOPIC EXPRESSION; STEM-CELL TRANSPLANTATION; ACTIVATED PROTEIN-KINASE; LONG-TERM OUTCOMES; LIVER-TRANSPLANTATION; SKELETAL-MUSCLE; GENE-THERAPY; MOUSE MODEL; SELECTIVE ELIMINATION;
D O I
10.1016/j.ymgme.2020.10.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mitochondrial disorders comprise a molecular and clinically diverse group of diseases that are associated with mitochondrial dysfunction leading to multi-organ disease. With recent advances in molecular technologies, the understanding of the pathomechanisms of a growing list of mitochondrial disorders has been greatly expanded. However, the therapeutic approaches for mitochondrial disorders have lagged behind with treatment options limited mainly to symptom specific therapies and supportive measures. There is an increasing number of clinical trials in mitochondrial disorders aiming for more specific and effective therapies. This review will cover different treatment modalities currently used in mitochondrial disorders, focusing on recent and ongoing clinical trials.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [21] Clinical trials update
    Lewis, JJ
    CELL STRESS & CHAPERONES, 2000, 5 (04): : 377 - 377
  • [22] 2025 Clinical Trials Update on Hemophilia, VWD, and Rare Inherited Bleeding Disorders
    Jiang, Debbie
    Wang, Michael
    Wheeler, Allison P.
    Croteau, Stacy E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (04) : 666 - 684
  • [23] Strategies for treating mitochondrial disorders: An update
    Scarpelli, Mauro
    Todeschini, Alice
    Rinaldi, Fabrizio
    Rota, Silvia
    Padovani, Alessandro
    Filosto, Massimiliano
    MOLECULAR GENETICS AND METABOLISM, 2014, 113 (04) : 253 - 260
  • [24] Clinical Trials Network Update
    Pappas, Virginia
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (02) : 13N - 13N
  • [25] Clinical trials and protocols update
    Lerner, SP
    UROLOGIC ONCOLOGY, 2001, 6 (01): : 31 - 32
  • [26] Update on clinical trials in dysphagia
    Logemann, Jeri A.
    DYSPHAGIA, 2006, 21 (02) : 116 - 120
  • [27] Accrual to clinical trials - an update
    Plant, R. E.
    Chauhan, M.
    Nelson, L.
    Fennell, D.
    Ahmed, S. I.
    LUNG CANCER, 2016, 91 : S29 - S30
  • [28] Update on Clinical Trials in Dysphagia
    Jeri A. Logemann
    Dysphagia, 2006, 21 : 116 - 120
  • [29] Update on mitochondrial fatty acid oxidation disorders
    Spiekerkoetter, Ute
    Mayatepek, Ertan
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 (05) : 467 - 468
  • [30] Update on Nuclear Mitochondrial Genes and Neurologic Disorders
    Goldstein, Amy
    Bhatia, Poonam
    Vento, Jodie M.
    SEMINARS IN PEDIATRIC NEUROLOGY, 2012, 19 (04) : 181 - 193